Dual I-O: Experience in Mesothelioma

Prof. Dr. Arnaud Scherpereel, Dept of Pulmonary & Thoracic Oncology, University Hospital (CHU) Lille, France

Prof. Scherpereel discusses a 73 year old female patient with epithelioid malignant pleural mesothelioma. He discusses his approach to managing this patient, including efficacy parameters, as well as management of a pulmonary immune related adverse event.

Dual I-O: Experience in NSCLC

Prof. Dr. Martin Reck Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Germany

Prof. Reck discusses a 63 year old male patient with metastatic adenocarcinoma of the lung. He discusses his approach to managing this patient, including efficacy parameters, as well as management of hyperthyreosis which was experienced by the patient.

Meet-the-Expert:

Interactive Panel Discussion

Topics discussed by Prof Scherpereel and Prof Reck included integrating the patient in treatment decision making, maintaining normality for patients whilst receiving treatment, patient selection for dual immunotherapy regimens, communicating to the patient on treatment options and rationale for treatment selection as well as rationale for discontinuation of immunotherapy, management of immune-mediated adverse reactions, rechallenging and treatment sequencing.